March 12, 2018 / 11:44 AM / 7 months ago

BRIEF-Strongbridge Biopharma Reports Q4 GAAP Loss Per Share $0.47

March 12 (Reuters) - Strongbridge Biopharma Plc:

* REPORTS FULL-YEAR 2017 FINANCIAL RESULTS

* Q4 NON-GAAP LOSS PER SHARE $0.31

* Q4 GAAP LOSS PER SHARE $0.47

* Q4 EARNINGS PER SHARE VIEW $-0.32 -- THOMSON REUTERS I/B/E/S

* SEES FY 2018 REVENUE $16 MILLION TO $19 MILLION

* ‍ MACRILEN PRODUCT LAUNCH ON TRACK FOR MID-2018​

* QTRLY ‍NET REVENUES OF $3.0 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below